Literature DB >> 29979235

Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection.

Ryan P Werntz1, Shane M Pearce2, Scott E Eggener1.   

Abstract

PURPOSE OF REVIEW: Examine and discuss indications, technique, and outcomes for robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer. RECENT
FINDINGS: Open RPLND has been the longstanding standard of care for both primary and post chemotherapy RPLND. Recently, robotic RPLND has been an attractive option with the intent of reducing the morbidity associated with open surgery while providing identical oncologic efficacy. Naysayers of robotic RPLND suggest it is often inappropriately used as a staging procedure and consequently can compromise oncologic efficacy.
SUMMARY: Robotic RPLND is being evaluated as a therapeutic equivalent to open RPLND. On the basis of limited published data with modest follow-up from experienced centers, robotic RPLND appears to provide effective staging and therapeutic data mirroring that of open surgery.

Entities:  

Mesh:

Year:  2018        PMID: 29979235     DOI: 10.1097/MOU.0000000000000530

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  2 in total

1.  Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.

Authors:  Andrew D Supron; Joseph G Cheaib; Michael J Biles; Zeyad Schwen; Mohamad Allaf; Phillip M Pierorazio
Journal:  J Robot Surg       Date:  2020-06-22

Review 2.  Robot-assisted retroperitoneal lymphadenectomy: The state of art.

Authors:  Gilberto J Rodrigues; Giuliano B Guglielmetti; Marcelo Orvieto; Kulthe Ramesh Seetharam Bhat; Vipul R Patel; Rafael F Coelho
Journal:  Asian J Urol       Date:  2020-10-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.